Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2018 | $111,224 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2018 | $20,975 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2018 | $495,412 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2018 | $15,595 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $6,000,000 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $3,450,000 | | tax credit/rebate |
Immunex RI Corporation | Amgen | Rhode Island | state | 2018 | $3,255,000 | | tax credit/rebate |
Novartis Corporation | Novartis | West Virginia | state | 2018 | undisclosed | | tax credit/rebate |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2017 | undisclosed | | enterprise zone |
Pfizer, Inc. | Pfizer | Missouri | local | 2017 | | $220,000,000 | loan or bond financing |
Impax Laboratories USA, LLC | Amneal Pharmaceuticals | Pennsylvania | state | 2017 | $150,000 | | tax credit/rebate |
PAREXEL International Corp. | Parexel International | Pennsylvania | state | 2017 | $69,000 | | tax credit/rebate |
Impax Laboratories USA, LLC | Amneal Pharmaceuticals | Pennsylvania | state | 2017 | $200,000 | | grant |
Pfizer, Inc. | Pfizer | Tennessee | local | 2017 | $2,582,313 | | property tax abatement |
Janssen Research & Development, LLC | Johnson & Johnson | Pennsylvania | state | 2017 | $4,768,953 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2017 | $1,494,073 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2017 | $1,113,133 | | tax credit/rebate |
Spark Therapeutics, LLC | Roche | Pennsylvania | state | 2017 | $790,740 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | | tax credit/rebate |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2017 | $720,954 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2017 | $693,503 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2017 | $506,455 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2017 | $160,094 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2017 | $93,554 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2017 | $83,373 | | tax credit/rebate |
Liquent, Inc. | Parexel International | Pennsylvania | state | 2017 | $65,812 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Pennsylvania | state | 2017 | $26,749 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | Pennsylvania | state | 2017 | $19,037 | | tax credit/rebate |
Versum Materials, Inc. | Merck KGaA (EMD) | Arizona | state | 2017 | $2,100,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $600,000 | | tax credit/rebate |
AstraZeneca Pharmaceuticals LP | AstraZeneca | Indiana | state | 2017 | $200,000 | | training reimbursement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $190,111 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,639 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,669 | | property tax abatement |
Dr. Reddys Laboratories Louisiana LLC | Dr. Reddy's Laboratories | Louisiana | local | 2017 | $1,009,926 | | property tax abatement |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $677,616 | | tax credit/rebate |
Abiomed Inc | Johnson & Johnson | Massachusetts | state | 2017 | $750,000 | | tax credit/rebate |
EMD Holding Corporation | Merck KGaA (EMD) | Massachusetts | state | 2017 | $1,200,000 | | tax credit/rebate |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Massachusetts | state | 2017 | $1,875,000 | | tax credit/rebate |
Acorda Therapeutics, Inc. | Acorda Therapeutics | Massachusetts | state | 2017 | $495,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2017 | $525,000 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2017 | $4,134 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2017 | $4,582 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2017 | $30,972 | | tax credit/rebate |
Emergent Biosolutions, Inc. | Emergent BioSolutions | Maryland | state | 2017 | $32,037 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2017 | $45,454 | | tax credit/rebate |
United Therapeutics Corporation and Subs. | United Therapeutics | Maryland | state | 2017 | $54,182 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2017 | $58,747 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2017 | $126,234 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2017 | $183,559 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2017 | $385,562 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2017 | $534,013 | | tax credit/rebate |
MedImmune, LLC | AstraZeneca | Maryland | state | 2017 | $1,939,088 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2017 | $3,242 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2017 | $7,824 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2017 | $28,805 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2017 | $39,799 | | property tax abatement |
Intervet, Inc. | Merck | Nebraska | state | 2017 | undisclosed | | tax credit/rebate |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | Kansas | local | 2017 | $37,036 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2017 | $2,960,521 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2017 | $2,525,507 | | tax credit/rebate |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2017 | $1,817,000 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2017 | $1,773,000 | | tax credit/rebate |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2017 | $1,008,259 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2017 | $600,562 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2017 | $540,625 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2017 | $412,873 | | tax credit/rebate |
Regeneron - 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2017 | $279,865 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2017 | $275,871 | | tax credit/rebate |
Regeneron - 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2017 | $234,700 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2017 | $210,093 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2017 | $150,152 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2017 | $42,107 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2017 | $17,711 | | tax credit/rebate |
Regeneron Renovation/Equipment | Regeneron Pharmaceuticals | New York | local | 2017 | $12,295 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2017 | $3,885 | | tax credit/rebate |
Regeneron Renovation | Regeneron Pharmaceuticals | New York | local | 2017 | $3,178 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS | Johnson & Johnson | Tennessee | local | 2017 | undisclosed | | property tax abatement |
PFIZER, INC. | Pfizer | Tennessee | local | 2017 | undisclosed | | property tax abatement |
Merck & Co., Inc. | Merck | Texas | state | 2017 | $6,000,000 | | grant |
ZYMOGENETICS, INC. | Bristol-Myers Squibb | Washington | state | 2017 | $5,971,568 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2017 | $2,436,956 | | tax credit/rebate |
NOVO NORDISK RESEARCH CENTER SEATTLE, INC. | Novo Holdings A/S | Washington | state | 2017 | $2,185,140 | | tax credit/rebate |
SEATTLE GENETICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $1,515,773 | | tax credit/rebate |
GILEAD SCIENCES, INC. | Gilead Sciences | Washington | state | 2017 | $333,444 | | tax credit/rebate |
CASCADIAN THERAPEUTICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $157,351 | | tax credit/rebate |
IMMUNE DESIGN CORP. | Merck | Washington | state | 2017 | $115,926 | | tax credit/rebate |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2017 | $249,388 | | training reimbursement |
AVANIR PHARMACEUTICALS INC | Otsuka Pharmaceutical | California | state | 2017 | $12,225 | | training reimbursement |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Kansas | state | 2017 | undisclosed | | grant |
Merck (2015) | Merck | Virginia | state | 2017 | $450,000 | | training reimbursement |
Abbott Laboratories Retrain | Abbott Laboratories | Virginia | state | 2017 | $65,639 | | training reimbursement |
Abbott Laboratories. | Abbott Laboratories | Virginia | state | 2017 | $34,078 | | training reimbursement |
Zoetis, Inc. and Subsidiaries | Zoetis | Iowa | State | 2017 | $2,499,000 | | Tax credit |
Cambrex Charles City, Inc. | Cambrex | Iowa | State | 2017 | $300,898 | | grant/loan hybrid program |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2017 | $2,511,374 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2017 | $2,266,743 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2017 | $467,431 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2017 | $184,344 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $143,927 | | tax credit/rebate |